Delivery Order SPE2DB20D3101-SPE2DB22FQWA2
Award Date
9/24/22
Potential Completion Date
9/26/22
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humira (adalimumab) autoinjector pens. The contract, valued at $1,761.66, is a delivery order on an existing Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (the parent company of Amerisourcebergen Drug Corp). This IDC, worth up to $999,999,999.00, serves as the primary vehicle for Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Humira (Adalimumab) auto-injector pens. The contract is a delivery order with a firm-fixed price of $49,000.29 and a performance period ending on September 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract, worth $16,460.11, is for the delivery of Humira (adalimumab) 40 mg/0.4 mL auto-injector pens. The contract has an ultimate completion date of October 12, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as the parent company. This contract is a delivery order under a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) autoinjector pens. The award, a Delivery Order valued at $42,560.00, has a firm fixed price and is not set aside for any specific business category. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen, through its Corporate Office division, will deliver the Humira pens to support...
This federal contract award is for the delivery of Humira (adalimumab) auto-injector pens to the Defense Logistics Agency (DLA), a component of the Department of Defense. The award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $64,536.16, is for the delivery of Humira (adalimumab) autoinjector pens to support military healthcare programs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with a ceiling value of $999,999,999.00. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Humira (adalimumab) auto-injector pens. The contract, valued at $4,612.28, is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,231.97 firm fixed-price delivery order is for the supply of Humira (adalimumab) auto-injector pens, a specialty medication used to treat various autoimmune conditions. The award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Humira (adalimumab) autoinjector pens. The $17,895.40 contract has a completion date of May 20, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and...
This federal contract award is for the delivery of Humira (adalimumab) auto-injector pens to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract is a delivery order valued at $3,574.56, with a firm fixed price pricing type. It has an ultimate completion date of April 1, 2022 and was awarded on March...